cbdMD (YCBD) Capital Expenditures (2016 - 2025)

cbdMD (YCBD) has 10 years of Capital Expenditures data on file, last reported at $164802.0 in Q4 2025.

• For the quarter ending Q4 2025, Capital Expenditures changed 0.25% year-over-year to $164802.0; the trailing twelve-month figure through Dec 2025 stood at $184587.0 (up 8.73% YoY), and the FY2025 full-year result was $184172.0, down 3.08% from the prior year.
• Capital Expenditures climbed to $164802.0 in Q4 2025, from $2804.0 in the prior quarter.
• In the past five years, Capital Expenditures ranged from a high of $231030.0 in Q4 2021 to a low of -$102390.0 in Q1 2023.
• A 5-year average of $93365.1 and a median of $102389.0 in 2023 frame the typical range for Capital Expenditures.
• Across the five-year window, Capital Expenditures soared 643.93% in 2022 and sank 171.72% in 2023, its largest moves.
• Tracing YCBD's Capital Expenditures over 5 years: stood at $231030.0 in 2021, then decreased by 23.23% to $177370.0 in 2022, then increased by 4.1% to $184635.0 in 2023, then retreated by 10.97% to $164387.0 in 2024, then grew by 0.25% to $164802.0 in 2025.
• Business Quant data shows YCBD's Capital Expenditures at $164802.0 in Q4 2025, $2804.0 in Q3 2025, and $1475.0 in Q2 2025.